BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+10.7%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.69T
AUM Growth
+$204B
(+8.2%)
Cap. Flow
+$492M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
19.5%
Holding
5,172
New
192
Increased
1,726
Reduced
2,546
Closed
177
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.37B |
| 2 |
Zoom
ZM
|
+$1.88B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.5B |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.43B |
| 5 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
IAC Inc
IAC
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$809M |
| 5 |
Meta Platforms (Facebook)
META
|
+$765M |
Sector Composition
| 1 | Technology | 22.69% |
| 2 | Healthcare | 14.52% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.66% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Corsair Gaming
CRSR
$948M
| $43.4M | ﹤0.01% |
+2,161,360
| New | +$43.4M |
|
|
XENT
2327
DELISTED
Intersect ENT, Inc
XENT
| $43.2M | ﹤0.01% |
2,649,914
-68,156
| -3% | -$1.11M |
|
2328
SunCoke Energy
SXC
$669M
| $43.2M | ﹤0.01% |
12,630,431
-413,602
| -3% | -$1.41M |
|
|
GOOD
2329
Gladstone Commercial Corp
GOOD
$606M
| $43.1M | ﹤0.01% |
2,555,104
-197,633
| -7% | -$3.33M |
|
|
NVEE
2330
DELISTED
NV5 Global
NVEE
| $43M | ﹤0.01% |
3,259,436
-6,156
| -0.2% | -$81.2K |
|
2331
Ingles Markets
IMKTA
$1.31B
| $43M | ﹤0.01% |
1,129,370
+39,232
| +4% | +$1.49M |
|
|
LGF.B
2332
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $43M | ﹤0.01% |
4,925,973
-55,447
| -1% | -$484K |
|
2333
Newmark Group
NMRK
$3.39B
| $42.9M | ﹤0.01% |
9,935,659
-714,824
| -7% | -$3.09M |
|
|
FLXN
2334
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $42.9M | ﹤0.01% |
4,123,141
+691,089
| +20% | +$7.19M |
|
|
TCRR
2335
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $42.8M | ﹤0.01% |
2,106,589
+1,012,572
| +93% | +$20.6M |
|
2336
Geron
GERN
$810M
| $42.8M | ﹤0.01% |
24,589,040
+5,188,676
| +27% | +$9.03M |
|
2337
ANI Pharmaceuticals
ANIP
$2.14B
| $42.7M | ﹤0.01% |
1,514,997
-12,327
| -0.8% | -$348K |
|
|
BOWXU
2338
DELISTED
BowX Acquisition Corp. Unit
BOWXU
| $42.7M | ﹤0.01% |
+4,158,000
| New | +$42.7M |
|
|
GMRE
2339
Global Medical REIT
GMRE
$513M
| $42.6M | ﹤0.01% |
3,153,554
-23,216
| -0.7% | -$313K |
|
|
PRVB
2340
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $42.5M | ﹤0.01% |
3,314,151
+428,534
| +15% | +$5.5M |
|
|
LDL
2341
DELISTED
Lydall, Inc.
LDL
| $42.3M | ﹤0.01% |
2,559,303
-73,461
| -3% | -$1.22M |
|
2342
Cemex
CX
$13.8B
| $42.3M | ﹤0.01% |
11,129,763
+6,539,626
| +142% | +$24.9M |
|
2343
iShares MSCI Mexico ETF
EWW
$1.94B
| $42.1M | ﹤0.01% |
1,262,059
-899,963
| -42% | -$30M |
|
|
QUOT
2344
DELISTED
Quotient Technology Inc
QUOT
| $42.1M | ﹤0.01% |
5,698,675
-172,261
| -3% | -$1.27M |
|
|
CNST
2345
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $42M | ﹤0.01% |
2,071,665
+230,734
| +13% | +$4.67M |
|
2346
York Water
YORW
$439M
| $42M | ﹤0.01% |
992,888
-22,955
| -2% | -$970K |
|
2347
Kearny Financial
KRNY
$407M
| $41.7M | ﹤0.01% |
5,783,782
+108,784
| +2% | +$784K |
|
|
SRE.PRB
2348
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $41.7M | ﹤0.01% |
425,398
+7,274
| +2% | +$713K |
|
2349
Akero Therapeutics
AKRO
$3.43B
| $41.7M | ﹤0.01% |
1,353,758
+323,776
| +31% | +$9.97M |
|
2350
TrueCar
TRUE
$210M
| $41.6M | ﹤0.01% |
8,326,225
-176,373
| -2% | -$882K |
|